184 related articles for article (PubMed ID: 16483388)
1. Treatment of the heart in Duchenne muscular dystrophy.
Baxter P
Dev Med Child Neurol; 2006 Mar; 48(3):163. PubMed ID: 16483388
[No Abstract] [Full Text] [Related]
2. Corticosteroid treatment retards development of ventricular dysfunction in Duchenne muscular dystrophy.
Finsterer J; Stöllberger C
Neuromuscul Disord; 2009 Jan; 19(1):74; author reply 75. PubMed ID: 19070488
[No Abstract] [Full Text] [Related]
3. Cerebral infarction in Duchenne muscular dystrophy.
Tsakadze N; Katzin LW; Krishnan S; Behrouz R
J Stroke Cerebrovasc Dis; 2011; 20(3):264-5. PubMed ID: 20621521
[TBL] [Abstract][Full Text] [Related]
4. Duchenne muscular dystrophy: how bad is the heart?
McNally EM
Heart; 2008 Aug; 94(8):976-7. PubMed ID: 18625791
[No Abstract] [Full Text] [Related]
5. Effects of angiotensin-converting enzyme inhibitors and/or beta blockers on the cardiomyopathy in Duchenne muscular dystrophy.
Viollet L; Thrush PT; Flanigan KM; Mendell JR; Allen HD
Am J Cardiol; 2012 Jul; 110(1):98-102. PubMed ID: 22463839
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting-enzyme inhibitors versus steroids as first-line drug treatment in Duchenne muscular dystrophy.
Chabrier S; Desguerre I; Porte M; Payet C; Rivier F;
Dev Med Child Neurol; 2010 Nov; 52(11):1067-8. PubMed ID: 20636389
[No Abstract] [Full Text] [Related]
7. Cardiac management of ventilator-assisted individuals with Duchenne muscular dystrophy.
O'Brien L; Varadi R; Goldstein RS; Evans RA
Chron Respir Dis; 2014 May; 11(2):103-10. PubMed ID: 24728656
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibitors and beta-blockers in cardiac asymptomatic patients with Duchenne muscular dystrophy.
Fayssoil A
Indian Heart J; 2010; 62(3):273. PubMed ID: 21275309
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy.
American Academy of Pediatrics Section on Cardiology and Cardiac Surgery
Pediatrics; 2005 Dec; 116(6):1569-73. PubMed ID: 16322188
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic nihilism in Duchenne cardiomyopathy.
Rein J
Pediatrics; 2006 May; 117(5):1864; author reply 1865. PubMed ID: 16651360
[No Abstract] [Full Text] [Related]
11. Duchenne muscular dystrophy; a cardiomyopathy that can be prevented?
Mulder BJ; van der Wall EE
Int J Cardiovasc Imaging; 2009 Jan; 25(1):65-7. PubMed ID: 18830686
[No Abstract] [Full Text] [Related]
12. [Management of myocardial damage in muscular dystrophy].
Tamura T
Brain Nerve; 2011 Nov; 63(11):1217-28. PubMed ID: 22068474
[TBL] [Abstract][Full Text] [Related]
13. Left ventricular function and response to enalapril in patients with duchenne muscular dystrophy during the second decade of life.
Ramaciotti C; Heistein LC; Coursey M; Lemler MS; Eapen RS; Iannaccone ST; Scott WA
Am J Cardiol; 2006 Sep; 98(6):825-7. PubMed ID: 16950195
[TBL] [Abstract][Full Text] [Related]
14. Does ACE inhibitor therapy delay onset and progression of cardiac dysfunction in duchenne muscular dystrophy?
Hirano M
Curr Neurol Neurosci Rep; 2006 Jan; 6(1):35-6. PubMed ID: 16469269
[No Abstract] [Full Text] [Related]
15. Effects of steroids and angiotensin converting enzyme inhibition on circumferential strain in boys with Duchenne muscular dystrophy: a cross-sectional and longitudinal study utilizing cardiovascular magnetic resonance.
Hor KN; Mazur W; Taylor MD; Al-Khalidi HR; Cripe LH; Jefferies JL; Raman SV; Chung ES; Kinnett KJ; Williams K; Gottliebson WM; Benson DW
J Cardiovasc Magn Reson; 2011 Oct; 13(1):60. PubMed ID: 22011358
[TBL] [Abstract][Full Text] [Related]
16. Becker muscular dystrophy-related cardiomyopathy: a favorable response to medical therapy.
Doing AH; Renlund DG; Smith RA
J Heart Lung Transplant; 2002 Apr; 21(4):496-8. PubMed ID: 11927228
[TBL] [Abstract][Full Text] [Related]
17. Randomised placebo-controlled trial of combination ACE inhibitor and beta-blocker therapy to prevent cardiomyopathy in children with Duchenne muscular dystrophy? (DMD Heart Protection Study): a protocol study.
Bourke JP; Watson G; Muntoni F; Spinty S; Roper H; Guglieri M; Speed C; McColl E; Chikermane A; Jayawant S; Adwani S; Willis T; Wilkinson J; Bryant A; Chadwick T; Wood R; Bushby K;
BMJ Open; 2018 Dec; 8(12):e022572. PubMed ID: 30573480
[TBL] [Abstract][Full Text] [Related]
18. Cardiac monitoring and treatment for children and adolescents with neuromuscular disorders.
Bourke JP
Dev Med Child Neurol; 2006 Mar; 48(3):164. PubMed ID: 16483389
[No Abstract] [Full Text] [Related]
19. Cardiac management in neuromuscular diseases.
Allen HD; Thrush PT; Hoffman TM; Flanigan KM; Mendell JR
Phys Med Rehabil Clin N Am; 2012 Nov; 23(4):855-68. PubMed ID: 23137741
[TBL] [Abstract][Full Text] [Related]
20. Intracardiac thrombus and cerebral infarction in a patient with duchenne muscular dystrophy.
Gimenez-Muñoz A; Capablo JL; Alarcia R; Torné L; Errea JM
J Clin Neuromuscul Dis; 2009 Dec; 11(2):79-80. PubMed ID: 19955989
[No Abstract] [Full Text] [Related]
[Next] [New Search]
